Canada markets closed

CSPC Pharmaceutical Group Limited (CVG.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.7442-0.0016 (-0.21%)
At close: 08:01AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 9.00B
Enterprise Value 7.39B
Trailing P/E 11.58
Forward P/E 10.98
PEG Ratio (5 yr expected) 7.95
Price/Sales (ttm)2.16
Price/Book (mrq)2.05
Enterprise Value/Revenue 1.81
Enterprise Value/EBITDA 6.67

Trading Information

Stock Price History

Beta (5Y Monthly) 0.70
52-Week Change 3-6.22%
S&P500 52-Week Change 326.14%
52 Week High 30.8750
52 Week Low 30.6226
50-Day Moving Average 30.7437
200-Day Moving Average 30.7305

Share Statistics

Avg Vol (3 month) 33.4k
Avg Vol (10 day) 35.13k
Shares Outstanding 511.9B
Implied Shares Outstanding 612.1B
Float 88.26B
% Held by Insiders 129.86%
% Held by Institutions 132.13%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.03
Forward Annual Dividend Yield 44.43%
Trailing Annual Dividend Rate 30.25
Trailing Annual Dividend Yield 334.06%
5 Year Average Dividend Yield 42.19
Payout Ratio 446.38%
Dividend Date 3N/A
Ex-Dividend Date 4May 31, 2024
Last Split Factor 28:5
Last Split Date 3Oct 16, 2020

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 18.67%
Operating Margin (ttm)23.59%

Management Effectiveness

Return on Assets (ttm)9.96%
Return on Equity (ttm)18.22%

Income Statement

Revenue (ttm)31.45B
Revenue Per Share (ttm)2.65
Quarterly Revenue Growth (yoy)1.90%
Gross Profit (ttm)N/A
EBITDA 7.93B
Net Income Avi to Common (ttm)5.87B
Diluted EPS (ttm)0.0600
Quarterly Earnings Growth (yoy)-15.10%

Balance Sheet

Total Cash (mrq)13.76B
Total Cash Per Share (mrq)1.16
Total Debt (mrq)706.9M
Total Debt/Equity (mrq)2.02%
Current Ratio (mrq)2.63
Book Value Per Share (mrq)2.80

Cash Flow Statement

Operating Cash Flow (ttm)4.18B
Levered Free Cash Flow (ttm)1.16B